Amy Putnam is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of immunology, particularly in the study of regulatory T cells. With a total of 4 patents, her work has implications for treating autoimmune and immune system-mediated disorders.

Latest Patents

One of her latest patents is titled "CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs." This invention provides methods for isolating CD127 immunosuppressive regulatory T cells, which can be greatly enriched for FoxP3. It also includes methods for expanding these isolated cells, pharmaceutical compositions of such cells, and their applications in treating various immune-related disorders.

Career Highlights

Amy Putnam is affiliated with the University of California, where she continues her research and innovation in immunology. Her work has garnered attention for its potential to advance therapeutic strategies in the field.

Collaborations

Some of her notable coworkers include Jeffrey A Bluestone and Weihong Liu, who have collaborated with her on various research projects.

Conclusion

Amy Putnam's contributions to immunology through her patents and research are paving the way for new treatments in autoimmune disorders. Her innovative work continues to inspire advancements in the field.

This text is generated by artificial intelligence and may not be accurate.